New Advances in Antiparasitic Drug Development: Targets, Strategies, and Challenges
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Parasitic Pathogens".
Deadline for manuscript submissions: 15 September 2025 | Viewed by 775
Special Issue Editor
Interests: pathogen biochemistry and pharmacology; neglected disease (leishmaniasis); drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the latest breakthroughs in antiparasitic drug development, exploring promising new targets, innovative strategies, and persistent challenges in combating parasitic diseases. It delves into the identification and validation of novel drug targets within parasites, encompassing crucial proteins, enzymes, and pathways essential for their survival and pathogenesis. Cutting-edge strategies, such as rational drug design, high-throughput screening, and drug repurposing, are examined in detail.
The Special Issue also addresses the significant challenges faced in antiparasitic drug development, including drug resistance, host toxicity, and the need for improved delivery systems. It highlights the importance of interdisciplinary collaborations and global partnerships to accelerate the discovery and development of effective antiparasitic therapies. This Special Issue centers upon the most recent advancements in antiparasitic drug development, investigating prospective novel targets, pioneering strategies, and enduring challenges in the fight against parasitic diseases.
Dr. Edson Roberto da Silva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malaria
- leishmania
- trypanossoma
- helminths
- antiparasitc drugs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
